President Trump’s Science Advisor Leads Conference Call with Government Science Leaders from Around the World on COVID-19
The Second Conference Call in a Series: WHOSTP Director Leads Scientific Diplomacy on COVID-19
THE WHITE HOUSE
Office of Science and Technology Policy
FOR IMMEDIATE RELEASE
March 12, 2020
Today, the Director of the White House Office of Science and Technology Policy, Dr. Kelvin Droegemeier, and Member of President’s Trump Task Force on Coronavirus, again led convening government science leaders including science ministers and chief advisors from Australia, Brazil, Canada, Germany, India, Italy, Japan, New Zealand, Singapore, Republic of Korea, and the United Kingdom to share information on integrating science into the COVID-19 response. Following the first call last week, we’ll continue ongoing scientific diplomacy weekly.
“Each of us has an important role and obligation to play in addressing the global outbreak of COVID-19. As chief science advisors, we have a firm understanding as to how critical it is for public health to bring the best available science and data to the forefront to assist in the development of solutions. This series of international collaboration efforts on science has led to actions on data sharing, access to COVID-19-related data and publications, and global unification for the health and safety of our citizens. From this international dialogue, the United States can build on the whole-of-government approach being led by Vice President Mike Pence’s team and the great work of the Trump Administration,” said the White House Office of Science and Technology Policy Director, Dr. Kelvin Droegemeier.
Highlights from the Call:
Dr. Kelvin Droegemeier provided the following takeaways from the conference call:
- Participants overwhelmingly supported efforts to make immediately available COVID-19 relevant peer-reviewed publications, data, and related research in PubMed Central and/or other publicly accessible repositories.
- Publicly available and timely data and publications is critical for addressing emerging infectious disease outbreaks.
- Artificial Intelligence (AI) can be used to organize and synthesize certain data and information to expedite this process.
- To ensure accessibility, ideally, data should be disseminated in machine and human readable formats, with broad rights for re-use and secondary analyses.
- AI tools and analyses should also be made publicly available in a timely manner.
- The science leaders discussed opportunities to promote and strengthen common data repositories, such as the Global Initiative on Sharing All Influenza Data (GISAID).
- Participants discussed responses to their stages of disease management and updated the group on cases from their countries.
For more information about the Coronavirus, please visit: https://www.cdc.gov/coronavirus/2019-ncov/index.html.